Added to these studies, the prevalence of NAFLD in populations with obesity varies geographically with a higher prevalence being reported in Central America and the Middle East, with 42.5% in children aged 8–11 years determined by alanine aminotransferase (ALT) levels in blood serum [4,5]. The gene discussed is GPT; the disease is obesity due to melanocortin 4 receptor deficiency.